First Time Loading...

bluebird bio Inc
NASDAQ:BLUE

Watchlist Manager
bluebird bio Inc Logo
bluebird bio Inc
NASDAQ:BLUE
Watchlist
Price: 1.06 USD -5.36% Market Closed
Updated: May 11, 2024

Net Margin
bluebird bio Inc

-418.4%
Current
-5 146%
Average
-8.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-418.4%
=
Net Income
-91.2m
/
Revenue
21.8m

Net Margin Across Competitors

Country US
Market Cap 204.3m USD
Net Margin
-418%
Country US
Market Cap 283.9B USD
Net Margin
9%
Country US
Market Cap 166.4B USD
Net Margin
13%
Country US
Market Cap 108.9B USD
Net Margin
37%
Country US
Market Cap 107.3B USD
Net Margin
29%
Country AU
Market Cap 134.9B AUD
Net Margin
17%
Country US
Market Cap 82.2B USD
Net Margin
2%
Country US
Market Cap 44.9B USD
Net Margin
-116%
Country US
Market Cap 43.1B USD
Net Margin
-33%
Country US
Market Cap 32.3B USD
Net Margin
12%
Country KR
Market Cap 40T KRW
Net Margin
25%

Profitability Report

View the profitability report to see the full profitability analysis for bluebird bio Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-418.4%
=
Net Income
-91.2m
/
Revenue
21.8m
What is the Net Margin of bluebird bio Inc?

Based on bluebird bio Inc's most recent financial statements, the company has Net Margin of -418.4%.